Correlation Between Adomos SA and Sanofi SA
Can any of the company-specific risk be diversified away by investing in both Adomos SA and Sanofi SA at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Adomos SA and Sanofi SA into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Adomos SA and Sanofi SA, you can compare the effects of market volatilities on Adomos SA and Sanofi SA and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Adomos SA with a short position of Sanofi SA. Check out your portfolio center. Please also check ongoing floating volatility patterns of Adomos SA and Sanofi SA.
Diversification Opportunities for Adomos SA and Sanofi SA
Average diversification
The 3 months correlation between Adomos and Sanofi is 0.17. Overlapping area represents the amount of risk that can be diversified away by holding Adomos SA and Sanofi SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sanofi SA and Adomos SA is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Adomos SA are associated (or correlated) with Sanofi SA. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sanofi SA has no effect on the direction of Adomos SA i.e., Adomos SA and Sanofi SA go up and down completely randomly.
Pair Corralation between Adomos SA and Sanofi SA
Assuming the 90 days trading horizon Adomos SA is expected to generate 13.11 times more return on investment than Sanofi SA. However, Adomos SA is 13.11 times more volatile than Sanofi SA. It trades about 0.06 of its potential returns per unit of risk. Sanofi SA is currently generating about -0.16 per unit of risk. If you would invest 0.02 in Adomos SA on September 27, 2024 and sell it today you would earn a total of 0.00 from holding Adomos SA or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Adomos SA vs. Sanofi SA
Performance |
Timeline |
Adomos SA |
Sanofi SA |
Adomos SA and Sanofi SA Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Adomos SA and Sanofi SA
The main advantage of trading using opposite Adomos SA and Sanofi SA positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Adomos SA position performs unexpectedly, Sanofi SA can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sanofi SA will offset losses from the drop in Sanofi SA's long position.Adomos SA vs. TotalEnergies SE | Adomos SA vs. LVMH Mot Hennessy | Adomos SA vs. Christian Dior SE | Adomos SA vs. BNP Paribas SA |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Other Complementary Tools
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Content Syndication Quickly integrate customizable finance content to your own investment portal |